dyslipidemia Flashcards

1
Q

statins MOA and when to take

A

inhibition of HMG-CoA reductase -> no conversion of HMG-CoA to mevalonate (RLS in cholesterol biosynthesis)
take in the evening; cholesterol synthesis is max from 12 - 2 AM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

statin metabolism

A

metabolized by CYP3A4
AE’s increased with concomitant use of CYP3A4 inhibitors, macrolides, azole antifungles, amiodarone, HN protease inhibitors, and gemfibrozil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

statin AE

A

increase in serum transaminases, myalgia, weakness, rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

statin contraindications

A

acute liver disease, persistent unexplained increased serum transaminases, pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

statin monitoring

A
LFTs (baselines and as clinically indicated thereafter); discontinue if >3x ULN
CK levels (baseline and if sxs appear); discontinue if >10x ULN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

statin avoiders

A
grapefruit juice (interferes with CYP3A4)
red yeast rice (contains statin active ingredient)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bile acid-binding resins agents

A

holesyramine, colestipol, colesevelam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BARs MOA

A

increase LDL catabolism and decrease cholesterol absorption
bind bile acids to prevent reabsorption -> increase cholesterol-using bile synthesis -> increase LDL uptake and clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BARs ADME

A

powder form mixed with water

not systemically absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BARs AE’s

A

GI (dyspepsia, bloating, abdominal discomfort)
hepatic (hypertriglyceridemia, increased serum transaminases)
pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BAR absorption interactions

A

levothyroxine, warfarin, verapamil, phenytoin (administer 1 hr before or 3-4 after BAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fibric acid derivatives agents

A

gemfibrozil, fenofibrate, fenofibric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

fibric acid derivatives MOA

A

increase VLDL clearance and decrease synthesis
activate nuclear transcription factor perioxisome proliferator activated receptor alpha (PPAR-alpha) on hepatocytes -> regulate lipid and glucose metabolism genes -> inhibit lipolysis and decrease hepatic fatty acid uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

fibric acid derivatives AE’s

A

increased serum transaminases, myalgia / weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

fibric acid derivatives contraindications

A

significant hepatic or renal dysfunction, primary biliary cirrhosis, pre-existing gall bladder disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

fibric acid derivatives intreactions

A

gemfibrozil > fenofibrate due to hepatic metabolism

17
Q

fibric acid derivatives monitoring

A

LFT’s - discontinue if > 3 x ULN

18
Q

Niacin (nicotinic acid) MOA

A

decrease LDL and VLDL synthesis
inhibition of triglyceride synthesis, inhibition of lipolysis, enhance LPL activity -> increase VLDL clearance
enhance HDL synthesis by blocking apoA breakdown

19
Q

Niacin (nicotinic acid) AE’s

A

flushing (prostaglandin mediated)

dyspepsia, peptic ulcer disease, nausea, hyperuricemia, decreased glucose tolerance, hepatotoxicity

20
Q

Niacin (nicotinic acid) contraindications

A

acute liver disease, pregnancy, gout

21
Q

cholesterol absorption inhibitor agent and MOA

A

ezetimibe
decrease cholesterol and LDL
inhibit cholesterol absorption at small intestine brush border -> decreased cholesterol delivery -> increased LDLR and clearance
not used much

22
Q

cholesterol absorption inhibitor AE’s

A

well tolerated; increases incidence of myopathy and increased transaminases when given with statin

23
Q

Fish oil MOA

A

reduce hepatic triglyceride synthesis and increase clearance

24
Q

fish oil AE’s

A

dyspepsia, taste aversion, prolonged bleeding time

25
Q

overall effects of statins

A

decreased cholesterol, decreases LDL, decreased trigs, increased HDL

26
Q

overall effects of BARs

A

decreased cholesterol, decreased LDL, increased VLDL

27
Q

overall effects of fibrates

A

decrease triglycerides, decrease cholesterol

28
Q

overall effects of niacin

A

decreased trigs, decreased cholesterol, increased HDL

29
Q

overall effects of Ezetimibe

A

decreased cholesterol, decreased LDL